| Literature DB >> 35942078 |
Hyungeun Song1,2, Erica A Israel1, Samantha Gutierrez-Arango1, Ashley C Teng1,3, Shriya S Srinivasan1,2, Lisa E Freed1, Hugh M Herr1,4.
Abstract
Background: Elucidating underlying mechanisms in subject-specific motor control and perception after amputation could guide development of advanced surgical and neuroprosthetic technologies. In this study, relationships between preserved agonist-antagonist muscle strain within the residual limb and preserved motor control and perception capacity are investigated.Entities:
Keywords: Motor control; Peripheral nervous system
Year: 2022 PMID: 35942078 PMCID: PMC9356003 DOI: 10.1038/s43856-022-00162-z
Source DB: PubMed Journal: Commun Med (Lond) ISSN: 2730-664X
Study population.
| Participant ID | Amputation type | Age (years) | Time since amputation (years) | Amputation etiology | Biological sex | Height (m) | Weight (kg) |
|---|---|---|---|---|---|---|---|
| AMl-1/BIO-A1 | AMI | 43 | 1.6 | Thermal Injury | Female | 1.68 | 81 |
| AMl-2/BIO-A2 | AMI | 55 | 2.7 | Trauma | Male | 1.73 | 77 |
| AMl-3/BIO-A3 | AMI | 50 | 1.0 | Trauma | Female | 1.68 | 81 |
| AMl-4/BIO-A4 | AMI | 58 | 1.2 | Trauma | Male | 1.90 | 93 |
| AMl-5/BIO-A5 | AMI | 32 | 0.5 | Trauma | Male | 1.75 | 75 |
| AMl-6/BIO-A6 | AMI | 29 | 0.6 | Trauma | Male | 1.68 | 84 |
| AMl-7/BIO-A7 | AMI | 48 | 0.5 | Trauma | Male | 1.70 | 75 |
| CTL-1/BIO-C1 | Standard | 25 | 1.4 | Oncological | Female | 1.64 | 54 |
| CTL-2/BIO-C2 | Standard | 62 | 2.7 | Trauma | Female | 1.65 | 81 |
| CTL-3/BIO-C3 | Standard | 25 | 2.0 | Talipes Equinovarus | Male | 1.78 | 108 |
| CTL-4/BIO-C4 | Standard | 39 | 2.7 | Trauma | Male | 1.60 | 63 |
| CTL-5/BIO-C5 | Ertl osteo-myoplasty | 62 | 2.6 | Trauma | Male | 1.80 | 97 |
| CTL-6/BIO-C6 | Standard | 61 | 5.3 | Trauma | Male | 1.73 | 91 |
| CTL-7/BIO-C7 | Standard | 46 | 8.7 | Trauma | Male | 1.78 | 75 |
| Mean ± s.d. | 45 ± 14 | 2.4 ± 2.2 | 1.72 ± 0.08 | 81 ± 14 |
AMI Agonist-antagonist Myoneural Interface, residual limbs of participants who underwent an AMI amputation (AMI-1-7), residual limbs of participants who underwent a Non-AMI control amputation (CTL-1-7), unaffected biologically-intact limbs (BIO-A1-7 and BIO-C1-7).
Fig. 1Clinical evaluation of sensorimotor responses and the degree of agonist-antagonist muscle strain (AMS) for participant’s residual limb muscles.
Shown in a, the Agonist-antagonist Myoneural Interface (AMI) amputation seeks to emulate physiological actuation of antagonistic muscle contraction and stretch. Ankle and subtalar AMI constructs are devised to create direct agonist-antagonist coupling for ankle dorsi and plantarflexion and for subtalar eversion and inversion. For the ankle joint AMI construct, the tibialis anterior (TA) is linked to the lateral gastrocnemius (GA), and for the subtalar joint AMI construct, the tibialis posterior (TP) is linked to the peroneus longus (PL). In b and c, the experimental setup is shown. Motor control and phantom limb perception capacity are assessed in free space without visual or any other functional feedback. Perturbed motor control and perception are anticipated if a critical degree of AMS is not preserved in the limb. Representations of the dorsi and plantarflexion synergic motor outputs are shown in green and red, respectively; efferent and afferent neural signals are shown in brown and yellow, respectively. Eversion and inversion were also tested but are not shown here. In d, AMS is computed from muscle fascicle changes during cyclic phantom ankle and subtalar joint movements. Here, the size and positioning of elements are representative and not to scale.